SILEXION THERAPEUTICS CORP Increase (Decrease) in Prepaid Expense
SILEXION THERAPEUTICS CORP (SLXN) reported Increase (Decrease) in Prepaid Expense of -$157.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was -$157.00K, a 176.59% decline year-over-year.
- SILEXION THERAPEUTICS CORP increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $959.00K, a 87.30% increase year-over-year.
- SILEXION THERAPEUTICS CORP increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$1.17M, a 5413.64% decline year-over-year.
- SILEXION THERAPEUTICS CORP increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $56.00K, a 86.57% decline year-over-year.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$157.00K 10-Q · filed 2026-08-14 | $802.00K 10-Q · filed 2026-08-14 | -$367.00K derived: sum of 3 quarters · filed 2026-08-14 | -$311.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $959.00K S-1/A · filed 2026-08-10 | -$210.00K derived: sum of 2 quarters · filed 2026-08-10 | -$154.00K derived: sum of 3 quarters · filed 2026-08-10 | $51.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$1.17M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$1.11M derived: sum of 2 quarters · filed 2026-08-10 | -$908.00K derived: sum of 3 quarters · filed 2026-08-14 | -$396.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | $56.00K 10-Q · filed 2025-11-12 | $261.00K derived: sum of 2 quarters · filed 2026-08-14 | $773.00K 10-Q · filed 2025-11-12 | $795.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $205.00K 10-Q · filed 2026-08-14 | $717.00K 10-Q · filed 2026-08-14 | $739.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.16M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $512.00K S-1/A · filed 2026-08-10 | $534.00K derived: sum of 2 quarters · filed 2026-08-10 | $951.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.01M derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | $22.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $439.00K derived: sum of 2 quarters · filed 2026-08-10 | $502.00K derived: sum of 3 quarters · filed 2026-08-10 | $631.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | $417.00K 10-Q · filed 2025-11-12 | $480.00K derived: sum of 2 quarters · filed 2025-11-12 | $609.00K 10-Q · filed 2025-11-12 | $738.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $63.00K 10-Q · filed 2025-08-12 | $192.00K 10-Q · filed 2025-08-12 | $321.00K derived: sum of 3 quarters · filed 2025-08-20 | $519.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2024-03-31 | $129.00K 10-Q · filed 2025-05-13 | $258.00K derived: sum of 2 quarters · filed 2025-08-20 | $456.00K derived: sum of 3 quarters · filed 2025-08-20 | $451.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2023-12-31 | $129.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | $327.00K derived: sum of 2 quarters · filed 2025-08-20 | $322.00K derived: sum of 3 quarters · filed 2025-08-20 | $329.00K 8-K · filed 2025-08-20 |
| 2023-09-30 | $198.00K 10-Q · filed 2024-11-14 | $193.00K derived: sum of 2 quarters · filed 2024-11-14 | $200.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$5.00K 10-Q · filed 2024-08-29 | $2.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |